Page last updated: 2024-12-05
kryptopyrrole
Description
Kryptopyrrole is a porphyrin derivative that has been proposed to play a role in various health conditions, including mental health issues, fatigue, and allergies. It is a naturally occurring compound found in small amounts in the body and is thought to be produced as a byproduct of heme synthesis. The exact mechanisms by which kryptopyrrole may exert its effects are not fully understood. Some studies suggest that it may interfere with neurotransmitter function, particularly with the metabolism of pyridoxine (vitamin B6). However, the evidence for these effects is limited and more research is needed. Kryptopyrrole is often studied in the context of alternative medicine and is sometimes used in conjunction with other therapies for conditions such as anxiety, depression, and chronic fatigue syndrome. However, its use is not supported by mainstream medical science and there is no clear consensus on its effectiveness or safety. Furthermore, there is no standard test for kryptopyrrole, and the interpretation of test results is often controversial. It is important to consult with a qualified healthcare professional before using any supplement or treatment related to kryptopyrrole.'
kryptopyrrole: metabolite in schizophrenia [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 10600 |
SCHEMBL ID | 891315 |
MeSH ID | M0058525 |
Synonyms (37)
Synonym |
AC-1902 |
brn 0107089 |
3-ethyl-2,4-dimethyl-1h-pyrrole |
nsc 62025 |
einecs 208-234-7 |
1h-pyrrole, 3-ethyl-2,4-dimethyl- |
pyrrole, 3-ethyl-2,4-dimethyl- |
kryptopyrrole |
2,4-dimethyl-3-ethylpyrrole |
nsc-62025 |
3-ethyl-2,4-dimethylpyrrole |
517-22-6 |
cryptopyrrole |
kryptopyrrol |
nsc62025 |
3-ethyl-2,4-dimethylpyrrole, 97% |
E0555 |
A7616 |
2,4-dimethyl-3-ethyl-1h-pyrrole |
AKOS006221229 |
unii-339v6s6pps |
339v6s6pps , |
5-20-05-00099 (beilstein handbook reference) |
FT-0610156 |
SCHEMBL891315 |
W-105871 |
DTXSID20199647 |
mfcd00005222 |
D70970 |
F0001-1346 |
SY051106 |
FS-5219 |
SB63946 |
CS-W016572 |
EN300-176676 |
3-ethy-2,4-dimethyl-1h-pyrrole |
Z1203730732 |
Research Excerpts
Dosage Studied
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 50.27
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 50.27 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 73.88 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 1 (14.29%) | 5.53% |
Reviews | 1 (14.29%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (71.43%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |